Soleno Therapeutics Inc. (SLNO)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
45.10
2.56 (6.02%)
At close: Jan 15, 2025, 11:36 AM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -17.03 | -0.82 | -1.11 | -7.86 | -2.79 | -2.69 | -1.03 | -1.04 | -1.1 | -0.14 | -1.47 | -0.84 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | -0.01 | 8.66 | 44.99 | n/a | 1.81 | n/a |
PB Ratio | 4.21 | 1.61 | 1.84 | 2.65 | 6.72 | 1.18 | 0.61 | 3.66 | 5.41 | -0.18 | -0.14 | -0.16 |
P/FCF Ratio | -26.62 | -0.8 | -1.18 | -4.79 | -5.77 | -3.07 | -1.62 | -0.93 | -1.64 | -0.42 | -6.13 | -1.55 |
P/OCF Ratio | -26.62 | -0.8 | -1.18 | -4.79 | -5.78 | -3.07 | -1.62 | -0.93 | -1.69 | -0.42 | -6.14 | -1.55 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | 0.01 | -9.3 | -26.58 | n/a | -0.3 | n/a |
Debt / Equity Ratio | 0.00 | 0.01 | 0.03 | 0.00 | 0.02 | n/a | n/a | n/a | n/a | -0.01 | -0.37 | -0.33 |
Quick Ratio | 14.89 | 2.14 | 2.80 | 5.83 | 4.26 | 13.14 | 10.38 | 1.84 | 1.83 | 6.38 | 0.11 | 0.21 |
Current Ratio | 14.89 | 2.14 | 2.80 | 5.83 | 4.26 | 13.14 | 10.38 | 2.23 | 2.01 | 6.46 | 0.11 | 0.21 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | -39.8 | 0.26 | 0.05 | n/a | 1.89 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -230.66 | n/a | n/a | n/a | -1.25 | -0.3 | -1.26 |
Return on Equity (ROE) | -0.25 | -1.96 | -1.66 | -0.34 | -2.4 | -0.44 | -0.59 | -3.51 | -4.93 | 1.34 | 0.10 | 0.19 |
Return on Assets (ROA) | -0.22 | -0.77 | -0.83 | -0.24 | -0.94 | -0.31 | -0.4 | -2.17 | -1.94 | -1.65 | -2.34 | -2.58 |
Return on Capital (ROIC) | -0.24 | -1.27 | -1.14 | -0.64 | -0.71 | -0.35 | -0.33 | -3.53 | -2.43 | -0.73 | 0.07 | 0.40 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 100.10% | -4.03% | 9.00% | n/a | 100.00% | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 1.01% | -831.63% | -4.10K% | n/a | -123.57% | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.88% | -830.14% | -4.10K% | n/a | -123.57% | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.78% | -938.12% | -3.14K% | n/a | -28.23% | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.64% | -933.06% | -2.74K% | n/a | -29.55% | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | 0.52% | -463.05% | -4.08K% | n/a | -26.83% | n/a |